Moleculin Biotech, Inc. (MBRX)
0.4856
0.00 (0.00%)
USD |
NASDAQ |
Oct 05, 16:00
0.4856
0.00 (0.00%)
After-Hours: 20:00
Moleculin Biotech EPS Diluted (Quarterly) : -1.402 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.402 |
| March 31, 2026 | -3.542 |
| December 31, 2025 | 4.829 |
| September 30, 2025 | -17.02 |
| June 30, 2025 | -28.68 |
| March 31, 2025 | -15.80 |
| December 31, 2024 | -48.71 |
| September 30, 2024 | -47.28 |
| June 30, 2024 | -1.698 |
| March 31, 2024 | -2.015 |
| December 31, 2023 | -5.126 |
| September 30, 2023 | -2.822 |
| June 30, 2023 | -3.019 |
| March 31, 2023 | -4.130 |
| December 31, 2022 | -3.547 |
| September 30, 2022 | -4.512 |
| June 30, 2022 | -3.556 |
| March 31, 2022 | -3.604 |
| December 31, 2021 | -1.483 |
| September 30, 2021 | -2.299 |
| June 30, 2021 | -2.238 |
| March 31, 2021 | -3.057 |
| Date | Value |
|---|---|
| December 31, 2020 | -3.431 |
| September 30, 2020 | -4.971 |
| June 30, 2020 | -15.30 |
| March 31, 2020 | -2.179 |
| December 31, 2019 | -7.474 |
| September 30, 2019 | -8.205 |
| June 30, 2019 | -0.0288 |
| March 31, 2019 | -12.51 |
| December 31, 2018 | -9.015 |
| September 30, 2018 | -6.828 |
| June 30, 2018 | -17.82 |
| March 31, 2018 | -7.433 |
| December 31, 2017 | -13.35 |
| September 30, 2017 | -12.56 |
| June 30, 2017 | -17.25 |
| March 31, 2017 | -2.030 |
| December 31, 2016 | -10.80 |
| September 30, 2016 | -10.80 |
| June 30, 2016 | -7.20 |
| March 31, 2016 | -4.50 |
| December 31, 2015 | -3.304 |
| September 30, 2015 | -1.415 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
| Biogen, Inc. | 0.6557 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.635M |
| Total Expenses (Quarterly) | 7.635M |
| Enterprise Value | -3.514M |
| Earnings Yield | -3.53K% |
| Normalized Earnings Yield | -3058.86 |